ArticleParasites & vectors2026
A targeted amplicon sequencing panel for cost-effective high-throughput genotyping of Aedes aegypti.
Article in Parasites & vectors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
9 authors.
Funding
Abstract
backgroundThe mosquito Aedes aegypti is the primary vector of several medically important arboviruses, including dengue, Zika, chikungunya, and yellow fever. Characterizing the genetic diversity of Ae. aegypti is essential to understand its evolutionary history and population dynamics and to evaluate vector control strategies. However, whole-genome sequencing (WGS) is often cost-prohibitive at scale due to the species' large genome size. Reduced-representation approaches offer a cost-effective alternative, yet a standardized genome-wide marker set for population genetic studies of Ae. aegypti is lacking.
methodsWe developed a targeted amplicon sequencing panel for cost-effective, high-throughput genotyping across 291 loci distributed throughout the Ae. aegypti genome. We evaluated its performance by comparing patterns of population structure and genetic admixture inferred from the amplicon sequences with those obtained from WGS data.
resultsIn silico analyses demonstrate that the amplicon panel reliably reproduces population structure patterns typically observed with WGS. It also effectively distinguishes among diverse laboratory colonies of Ae. aegypti and yields individual genetic admixture estimates consistent with WGS results.
conclusionsThis targeted amplicon sequencing panel enables high-throughput genotyping at reduced cost and provides a practical alternative to WGS for population genetic and genomic surveillance studies. It should facilitate large-scale genotyping of Ae. aegypti, particularly in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.